- 79
- 6 731
Fondazione Italiana Fegato - FIF ONLUS
Italy
Приєднався 20 січ 2021
Canale di youtube della Fondazione Italiana Fegato.
Fondata nel 2008 da un’idea illuminata del Prof. Claudio Tiribelli, professore di Gastroenterologia all’Università di Trieste e luminare nel campo dell’epatologia, la Fondazione Italiana Fegato (FIF) è un ente di ricerca riconosciuto dal MIUR specializzato nello studio sulle malattie epatiche e patologie correlate.
Nella sua attività scientifica, la FIF collabora con diverse organizzazioni a livello internazionale, dal Messico all’Indonesia, dall’Argentina agli Stati Uniti. Con tali paesi la FIF mantiene una collaborazione attiva e un continuo scambio di giovani ricercatori, scienziati, dottorandi che arrivano alla Fondazione per incrementare la loro esperienza e condividere con noi le loro competenze.
Fondata nel 2008 da un’idea illuminata del Prof. Claudio Tiribelli, professore di Gastroenterologia all’Università di Trieste e luminare nel campo dell’epatologia, la Fondazione Italiana Fegato (FIF) è un ente di ricerca riconosciuto dal MIUR specializzato nello studio sulle malattie epatiche e patologie correlate.
Nella sua attività scientifica, la FIF collabora con diverse organizzazioni a livello internazionale, dal Messico all’Indonesia, dall’Argentina agli Stati Uniti. Con tali paesi la FIF mantiene una collaborazione attiva e un continuo scambio di giovani ricercatori, scienziati, dottorandi che arrivano alla Fondazione per incrementare la loro esperienza e condividere con noi le loro competenze.
YW2024: "Tissue-derived Organoid Models and their Biomedical Applications" by Dr. Meritxell Huch
Meritxell Huch, PhD
Director
Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG)
Lise Meitner Excellence Program, Max Planck Society
Dresden, Germany
Title
"Tissue derived organoid models and their biomedical applications"
===============================================================
FOLLOW US:
LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/
Instagram - fondazioneitalianafegato
Facebook - it-it. fondazioneitalianafegato/
UA-cam: www.youtube.com/@fondazioneitalianafegato
Twitter: FondItaFegato
web: www.fegato.it
#FIFonlus #yellowebinar #liver #oneliver #loveyourliver
Director
Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG)
Lise Meitner Excellence Program, Max Planck Society
Dresden, Germany
Title
"Tissue derived organoid models and their biomedical applications"
===============================================================
FOLLOW US:
LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/
Instagram - fondazioneitalianafegato
Facebook - it-it. fondazioneitalianafegato/
UA-cam: www.youtube.com/@fondazioneitalianafegato
Twitter: FondItaFegato
web: www.fegato.it
#FIFonlus #yellowebinar #liver #oneliver #loveyourliver
Переглядів: 2
Відео
Servizio TRC Modena - 3 Novembre 2024
Переглядів 416 годин тому
Su TRC Modena si parla della nuova collaborazione sullo studio benefici dell'olio extravergine di oliva realizzata con Coop Alleanza 3.0 Quanto sappiamo sull'Olio EVO? 🫒🥣 Anche se ci sono già studi promettenti, la ricerca non si ferma! Aiutaci a sostenere il nostro progetto di ricerca Progetto O-liver www.paypal.com/donate/?campaign_id=2P7VJCP6F95L6 #olioevo #salute #fundraising #olioextravergi...
YW2024: "Circulating Biomarkers of Response to Systemic Treatments in Advanced HCC" -Claudia Campani
Переглядів 50Місяць тому
Claudia Campani, MD PhD Department of Experimental and Clinical Medicine, Internal Medicine and Hepatology Unit, University of Firenze, Florence, Italy Cordeliers Research Center, Sorbonne University, Inserm Paris Cité University, "Functional Genomics of Solid Tumors" team Ligue Nationale Contre le Cancer accredited team Labex OncoImmunology, Paris, France Title: "Circulating biomarkers of resp...
YW2024: "How to choose a murine model that best recapitulates human MASLD?" by Dr. Michele Vacca
Переглядів 472 місяці тому
Michele Vacca MD PhD Associate Professor Interdisciplinary Department of Medicine, Università degli Studi di Bari Aldo Moro, Bari - Italy Principal Investigator, “Hepatic Metabolism and MASLD” Lab The Roger Williams Institute of Hepatology Foundation for Liver Research London, UK TITLE "How to choose a murine model that best recapitulates human MASLD? An unbiased ranking based on proximity to h...
YW2024: "Compensated Advanced Chronic Liver Disease: Baveno VII Consensus and Beyond" Dr. Berzigotti
Переглядів 882 місяці тому
Annalisa Berzigotti MD PhD Head of Hepatology and Clinic Director ad Interim, University Clinic for Visceral Surgery and Medicine (UVCM), Inselspital, University Hospital of Bern; Associate Professor of Hepatology, University of Bern; Research group leader, DBMR Title: "Compensated Advanced Chronic Liver Disease: Baveno VII Consensus and Beyond" FOLLOW US: LinkedIn - www.linkedin.com/company/fo...
La Fondazione Italiana Fegato eccellenza da sostenere.Il Governatore Fedriga alla FIF (video FVG.TV)
Переглядів 524 місяці тому
📣"La Fondazione italiana fegato è un'eccellenza del Friuli Venezia Giulia che, nel tempo, ha saputo stringere collaborazioni a livello globale e realizzare importanti progetti internazionali. Un'intensa attività che ha arricchito il nostro sistema di salute, grazie a iniziative di ricerca, formazione ed educazione rivolte a tutte le fasce della popolazione" ➡️Lo ha affermato il governatore dell...
YW2024: "Lean MASLD: Facts or Function?" by Prof. Elisabetta Bugianesi
Переглядів 2344 місяці тому
Elisabetta Bugianesi Full Professor in Gastroenterology Scientific Director and Deputy Director Department of Medical Sciences University of Torino, Italy Title: "Lean MASLD: Facts or Function?" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafegato/ UA-cam: www.youtube.c...
YW2024: "Biomarkers for Risk Stratification and Chemoprevention of HCC" by Prof. Yujin Hoshida
Переглядів 724 місяці тому
Prof. Yujin Hoshida Director, Liver Tumor Translational Research Program University of Texas, Southwestern Medical Center Dallas TITLE: "Biomarkers for risk stratification and chemoprevention of hepatocellular carcinoma" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafeg...
YW2024: "Mythbusters: NAFLD or MASLD or DAFLD?" by Prof. Robert Lustig
Переглядів 3,2 тис.4 місяці тому
Robert Lustig, MD, MSL Emeritus Professor in Pediatrics, Division of Endocrinology, University of California, San Francisco (UCSF) Member, Institute for Health Policy Studies, UCSF TITLE: "Mythbusters: NAFLD or MASLD or DAFLD?" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneital...
YW2024: "Visualising & Understanding Neural Plasticity in Pancreatic Cancer Development" -Fanny Mann
Переглядів 474 місяці тому
Fanny Mann The Marseille Developmental Biology Institute (IBDM), France TITLE: "Visualising and understanding neural plasticity in pancreatic cancer development" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafegato/ UA-cam: www.youtube.com/@fondazioneitalianafegato Twit...
YW2024: "Hepatokines in MAFLD: from Bench to Clinic" by Prof. Aimin Xu
Переглядів 774 місяці тому
Prof. Aimin Xu Chair, Professor Department of Pharmacology and Pharmacy, The University of Hong Kong TITLE: "Hepatokines in MAFLD: from bench to clinic" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafegato/ UA-cam: www.youtube.com/@fondazioneitalianafegato Twitter: twit...
YW2024: "Juvenile Autoimmune Liver Disease" by Prof. Giorgina Mieli-Vergani
Переглядів 334 місяці тому
Giorgina Mieli-Vergani Professor of Paediatric Hepatology King's College London School of Medicine Title: "Juvenile Autoimmune Liver Disease" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafegato/ UA-cam: www.youtube.com/@fondazioneitalianafegato Twitter: Fon...
YW2024: "Severe neonatal hyperbilirubinemia and Crigler-Najjarr syndrome" by Andres Muro
Переглядів 184 місяці тому
Andrés Muro Principal Investigator, Group Leader, ICGEB (International Centre for Genetic Engineering and Biotechnology) Trieste, Italy Title: "Severe neonatal hyperbilirubinemia and Crigler-Najjarr syndrome: lessons from studies with animal models and patients" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook ...
YW2024: "Unveiling opportunities for precision therapeutics in liver cancer through..." -Carmen Wong
Переглядів 548 місяців тому
Dr. Carmen Wong Associate Professor Department of Pathology, The University of Hong Kong State Key Laboratory of Liver Research, The University of Hong Kong Centre for Oncology and Immunology, Hong Kong Science Park Title: "Unveiling opportunities for precision therapeutics in liver cancer through understanding the immune microenvironment" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazio...
YW2024: "Hepatitis D: New Developments" by Mario Rizzetto
Переглядів 488 місяців тому
Mario Rizzetto Honorary Professor of Gastroenterology University of Turin (Italy) Title: "Hepatitis D: New Developments" FOLLOW US: LinkedIn - www.linkedin.com/company/fondazioneitalianafegato/ Instagram - fondazioneitalianafegato Facebook - it-it. fondazioneitalianafegato/ UA-cam: www.youtube.com/@fondazioneitalianafegato Twitter: FondItaFegato web: www.f...
YW2023: "RNA Therapies in Age-Related Disorders" - Dr. Fabrizio d'Adda di Fagagna
Переглядів 6211 місяців тому
YW2023: "RNA Therapies in Age-Related Disorders" - Dr. Fabrizio d'Adda di Fagagna
YW2023: "Chromatin, Alternative Splicing and The Cure of An Hereditary Disease" - Dr. Kornblihtt
Переглядів 3311 місяців тому
YW2023: "Chromatin, Alternative Splicing and The Cure of An Hereditary Disease" - Dr. Kornblihtt
YW2023: "Immunotherapy for HCC: Challenges in Clinical Practice"
Переглядів 1311 місяців тому
YW2023: "Immunotherapy for HCC: Challenges in Clinical Practice"
YW2023: "Bariatric Surgery as Potential Treatment for NAFLD"
Переглядів 2011 місяців тому
YW2023: "Bariatric Surgery as Potential Treatment for NAFLD"
YW2023: "The Role of Bile Acids in Fatty Liver" - Dr. Rohit Kohli
Переглядів 7711 місяців тому
YW2023: "The Role of Bile Acids in Fatty Liver" - Dr. Rohit Kohli
YW2023: ‘’Immunotherapy Combinations for Advanced HCC‘’ - Lorenza Rimassa, MD
Переглядів 6511 місяців тому
YW2023: ‘’Immunotherapy Combinations for Advanced HCC‘’ - Lorenza Rimassa, MD
YW2023: ‘’Immunomodulatory Strategies for ALD: Why, How and When?‘’ - Dr. Antonio Riva
Переглядів 1611 місяців тому
YW2023: ‘’Immunomodulatory Strategies for ALD: Why, How and When?‘’ - Dr. Antonio Riva
YW2023: "Crosstalk between RNA Processing and DNA Repair in Cancer Development" - Dr. Gianluca Tell
Переглядів 511 місяців тому
YW2023: "Crosstalk between RNA Processing and DNA Repair in Cancer Development" - Dr. Gianluca Tell
YW2023: "Food and Exercise as Medicine: Metabolic and Molecular Effects" - Dr. Luigi Fontana
Переглядів 19911 місяців тому
YW2023: "Food and Exercise as Medicine: Metabolic and Molecular Effects" - Dr. Luigi Fontana
YW2023: "Tale of Two Projects: from Genetic Screening Cancer to Data Science" - Mario Rossi
Переглядів 2311 місяців тому
YW2023: "Tale of Two Projects: from Genetic Screening Cancer to Data Science" - Mario Rossi
YW2023: "SteatoSITE: A Gene-to-Outcome Data Commons for NAFLD Research"
Переглядів 2411 місяців тому
YW2023: "SteatoSITE: A Gene-to-Outcome Data Commons for NAFLD Research"
YW2023: "Interdisciplinary Management of Fatty Liver Disease" - Dr. Jeffrey Lazarus
Переглядів 911 місяців тому
YW2023: "Interdisciplinary Management of Fatty Liver Disease" - Dr. Jeffrey Lazarus
YW2023: "...Tumour Immune Microenvironment for Biomarker & Therapeutic Discovery in HCC" - Dr. Chew
Переглядів 2311 місяців тому
YW2023: "...Tumour Immune Microenvironment for Biomarker & Therapeutic Discovery in HCC" - Dr. Chew
YW2023: "...Phenotypic Plasticity in HCC to Mitigate Therapy Resistance & Tumor Recurrence" - Dr. Ma
Переглядів 11311 місяців тому
YW2023: "...Phenotypic Plasticity in HCC to Mitigate Therapy Resistance & Tumor Recurrence" - Dr. Ma
Conosci la FIF - Fondazione Italiana Fegato ONLUS
Переглядів 43Рік тому
Conosci la FIF - Fondazione Italiana Fegato ONLUS
Well done Noel, we miss you!
What an excellent presentation, it really opens so many possibilities for the understanding of chronic disease. Thank you
I am very very disappointed. once, some 5 or 6 y ago, Dr. Lustig made me awae about the sugar problem. But here, this presentation is just awful. he tries to whitewash being fat by constructing a paper tiger and engaging wrong arguments. At mark @7.00 you can observe how a statistics is getting constructed and abused : first you focus on an arbitrary threshold, in this case "obesity is BMI of 30+", then define the opposite as "nomal", and next you present the conundrum that in normal weight people obesity rises. At @8:28 he even starts to call people with a BMI of 30 "thin". ...holy crap.... Sorry, since when is a BMI between 25 and 30 normal weight? It is even medically rated as "overweight". By any means "normal" would be for BMI<25, as coarse and misleading that is. A child with 24 is NOT normal, becaus much lower portion of lean mass, wheeas an adult male with BMI 26 coud be normal. BMI is outdated. ...which just adds to the invalidity of the argument. Its complete BS. Just exaggarated at 11:00+ when he cites a study about a small population with missing HGH receptors and draws conclusions for the gneral popuplation... that's intellectual dishonesty to its purest. At 16:20 then he claims that, quote, "visceral fat is a consequence of chronic stress, not of diet." ...that's just becoming criminal... A bad mistake at 29:00. He showing a slide about effects of glucose and fructose ono the capablity of the liver to process fat. Frucose is bad, yes, but there is absolutely NO indication that glucose improve beta-oxidation, also from other studies. It also disrgards what s calle energy toxicity. Agan, BS, here va cherry picking. Bad mistake at 41:38 ... caling, qute, "methionine the second rarest amino acid in the diet"... very wrong, indeed. I do not kow o which diet he is referring to here, but diet tracking via cronometer, which uses public US dietary databases, is showing me daily quite the opposite. And btw, talking about "the diet" is quite an overgeneralisation. The part about fructose is ok, but fructose is from diet. Fatty liver, even in the beginning, directly spills over into visceral fat, which is inflammatory. Whether you eat a lot of fructose anfd 500 kcal too much every day or just 2000kcal per day too much of a "healthy" diet does not matter. Both make you fat and sick. And of course, hypertroph fat cells spill free FA like hell, making you sick. Obesity or too much fat is indeed making sick in 95% of all cases. Better to temove ths video, it is just bad
Excellent upload. Next, try interviewing Tim Noakes. Thank you.
An excellent podcast and all congrats to the host which didn't interrupt professor Lustig with personal questions as all these long-nails ladies and big muscles folks are doing around. Keep delivering humanity clear and clean information, waiting for other podcasts with Dr Bickman, Dr RickJohnson and other great health modern miners
Thank you for uploading
you need to give titles to the videos that make sense. this way noone knows what the videos are about and are also not searchable.
Greetings! Thank you very much for your feedback, we will incorporate your valuable suggestion in our current and future videos.